0001193125-14-185151.txt : 20140506 0001193125-14-185151.hdr.sgml : 20140506 20140506171536 ACCESSION NUMBER: 0001193125-14-185151 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20140506 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140506 DATE AS OF CHANGE: 20140506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VITAL THERAPIES INC CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36201 FILM NUMBER: 14818087 BUSINESS ADDRESS: STREET 1: 15222 AVENUE OF SCIENCE, SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92128 BUSINESS PHONE: 858-673-6840 MAIL ADDRESS: STREET 1: 15222 AVENUE OF SCIENCE, SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92128 8-K 1 d722796d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

May 6, 2014

 

 

VITAL THERAPIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36201   56-2358443

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

15010 Avenue of Science, Suite 200

San Diego, CA 92128

(Address of principal executive offices, including zip code)

(858) 673-6840

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01. Other Information.

On May 6, 2014, Vital Therapies, Inc. issued a press release announcing that the underwriters of its initial public offering have exercised in full their option to purchase an additional 675,000 shares of common stock from Vital Therapies at the initial public offering price of $12.00 per share, less the underwriting discount. A copy of this press release is attached hereto as Exhibit 99.1.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.

   

Description

99.1    Press Release of Vital Therapies, Inc., dated May 6, 2014.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VITAL THERAPIES, INC.
By:  

 /s/ Michael V. Swanson

 

Michael V. Swanson

Chief Financial Officer

Date: May 6, 2014

EXHIBIT INDEX

 

Exhibit No.

   

Description

99.1    Press Release of Vital Therapies, Inc., dated May 6, 2014.
 EX-99.1 2 d722796dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

VITAL THERAPIES ANNOUNCES FULL EXERCISE OF

UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

San Diego, Calif. — May 6, 2014 — Vital Therapies, Inc. (NASDAQ:VTL), a biotherapeutic company developing a cell-based therapy targeting treatment of all forms of acute liver failure, today announced that the underwriters of its initial public offering have exercised in full their option to purchase an additional 675,000 shares of common stock from Vital Therapies at the initial public offering price of $12.00 per share, less the underwriting discount. The sale of these additional shares of common stock closed earlier today, following the closing on April 23, 2014 of the sale of 4,500,000 shares by Vital Therapies. As a result, Vital Therapies has received aggregate gross proceeds from the offering of $62.1 million, before deducting underwriting discounts and other offering expenses.

BofA Merrill Lynch and Credit Suisse Securities (USA) LLC acted as joint book-running managers for the offering. William Blair & Company, L.L.C. and Canaccord Genuity Inc. acted as co-managers.

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on April 16, 2014. This offering was made solely by means of a prospectus, copies of which may be obtained from: BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department, Email: dg.prospectus_requests@baml.com, or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, Telephone: (800) 221-1037, Email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Vital Therapies, Inc.

Vital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting treatment of all forms of acute liver failure. The company’s lead product-candidate, ELAD, is an extracorporeal bio-artificial liver therapy currently in Phase 3 clinical trials. Vital Therapies, Inc. is based in San Diego, California. Vital Therapies® and ELAD® are trademarks of Vital Therapies, Inc.

Vital Therapies, Inc. Contact:

Terry Winters, Ph.D.

Co-Chairman & Chief Executive Officer

Duane Nash, M.D.

Executive Vice President, Chief Business Officer

Tel: (858) 673-6840

15010 Avenue of Science, San Diego, California, USA 92128

Tel 858.673.6840  —  Fax 858-673-6843

www.vitaltherapies.com

GRAPHIC 3 g722796g50b48.jpg GRAPHIC begin 644 g722796g50b48.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,# M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_ MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``Z`84#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]:/\`@I1^ MU?\`$C]C'X6VWC?P?X-T7QAX=LW\O7!<3RQW&F!B!',`G#1$G:QZJ2IY!)7X M3TK_`(.7?%ZZK;?;OACX;:R\U?M"P:C,LICR-VPD$!L9QD$9[5^NVM:+9^)= M'N].U"UM[[3[^%[:YMKB,20W$3J5='5N&5E)!!X()K\"O^"M'_!-V\_84^,/ M]I:';W%Q\-?%,SOHUR29/[.EY9K&5CSN49*%N7C'5F23'9A?9R]V:U.'%.K# MWX/0_=/X'?&SP[^T7\*=%\9^$[Y=0T+7K<3V\F,.AZ-&Z_PNC`JR]BI%=97X M'_\`!(?_`(*677[$/Q6'A_Q)=7$WPR\47"C48^7_`+'N#A5O8U&3@``2*O+( M`0&9%4_O1IFIVVM:;;WEG<0W=G=QK-!/#()(YHV`*NK#AE((((X(-8UZ+IRM MT-\/652-^I8K^<7]LO\`8K_;8UC]H36+KQEX<^*/C;5KR](/^*=^#>EPZ7&Y_P"0CKSR M7$RY&#^[B58SC/'S@9')QSZ64QQ,;SHP37G^A^S^%M'B'#NKC,IP<:T)6BY3 MM&S5](R;7?WDK]+VL??#W MQOJ6Y=.ADO!>Z?JCJ,F..?8C)(0"0CH`<8#LV`?ORN'&0J1JMU8\K>MNGR/A M^,,'F-#-:LLTH*C4F^;E22C9_P`MFTUYIO6]]0K\]?\`@H=_P71LOV4_C6W@ M?P+H.E^,K_1U9-=NKFZ>.WM+CC%O&4^\Z#._LI(7[P8#LO\`@L9_P4PC_8S^ M&7_"(^$[R)OB9XJMV^SLAW-H=JV5-VP_YZ'E8@?X@6.0FUOP\\&>#M=^,/Q` MT_0]'M;S6_$/B"\6WMX4S)-=3R-W)[DDDL3@%[WQ9ITD9EO+6PL)9KM%CG@\THZMLW?9WG= M$907>$*"2X`X3_@FG^P#H_[`_P`"XM*7[/?>,-;"77B'4T'$\P'RPQD\^3%D MA>FXEF(!;`^C*YZDH.?NK0Z*49\GOO4YWX3>*-4\:?#30]4US1YO#^N7EG&^ MHZ9*NO.-M)Y/EB;:?++@E=V.,XYQGTJ2BL> MIL?FC_P4=_X+"?&[_@FU\3])T'Q)\.?A_KFF^(;5KO2M6L;Z\CBN@C!98V5Q ME9$+(2H+#$B'/.!^AGPHUW4/%/PWT75-4N-'O+S4K5+MI])$GV&59!O1HO,^ M=KGPQN5U^`JN7:TQY=VF>RB, MB4_]>XK<_P""!W[3B_M&?\$Z_"]G=7#3:U\/)'\+7H9OF\N$*UJ0.NW[,\*9 MZ%HV],#[#'8/#5\BI8_#4U&<9N-2U]=+Q>K=E;MI=^1Y].I..)=*;NFKK]2S M_P`%(O\`@H'\1?V.OC'\-O"7@OPQX0\;:G\4K\Z;I&EW$]Q!?1R*8D:21ER@ MBWS+\QQ@!CR%8CWRQ_:'T7X8:;:Z;\4_'7PQ\.^+VC$]Q9Q:S':QJC$[2BW+ MK(5X(W$`'!X'2OCSX#VA_;>_X+D_$+X@2D7GA#]G72U\*:*W!C.J2B19V'8L MC->J3R1B$Y&`!7_X.=-`L]1_X)^:)?36\;WFG>,K,V\Q7YX@]M=*X!Z[6&,C MH2JGL*TCE>&JXG"97)>L59Z:1:OL[M]@]M.,)UEJELO3?\`&Y]P MP_M,?#FX\$ZEXFB\?>"YO#FBO''J&J1ZW;/9V#2,JH)9@^R/>03FOG?\`X+B?L)_!KX%_\$Y/%OB+P=\, M?!?AK7;.]TV.#4-/TN*"XB5[R)'`=1GE20?4&N'`Y7@*V,6"G.:E*?(K)-)7 M23>JZWT6R-*E:K&G[1)6M<^Z_P#ALSX/_P#15OAK_P"%-9?_`!VNX\*^+-*\ M<^'[75M$U+3]8TJ^7S+:\L;A+BWN%R1E)$)5AD$9!ZBO@'_@DQ_P3R^!_P`; MO^";'PTUOQ9\+/!>N:UK6GW7VW4;G34-W<$7=P@)E`#[@J@`@@C`P:^L/#&A M^%_^">'[&LUO)=3-X1^&.C75TKR'][]FB\R58QDG<^TA!DY8X[G%6_Q.6338_VH M=,C\20B0L(GGN3)=6$JY_A*F>!1CK(HS@5^VM//\D>68F-%OFBXJ2:Z][>DD MUZ6%A<1[:'-MK_7X'FO_``V9\'_^BK?#7_PIK+_X[7HMK=1W]M'/!)'-#,@> M.1&#*ZD9!!'!!'.17X^?L]^`M*'_``<_>.HXK*U@ATM;S4H8DA78)WTV$L^, M<,6F=\C!W'/Y72P,J4:4F^>$9ZVTYNFG;O^`86M*HI.71M?`_@G\+_``[\0K;3O#D&M:[$Y/B9\!O">G3>,%NOL,=GXS^U-FV\GS M=^R`A?\`7QD?,7,[1;O=22W7;;3S,,=[2G2E5C-W^5M_0^J/C/^U]^V-\,?!>IZQ#^S M;X*N[71[=[RYEMO&\=X?)12S[8=L4C,H&<+DD`@`DBOHGP_^V%\/;?PMHLGB M?QYX$\/:]>Z9:7UYIUWKMM;36K3P),`8Y)`Z@JX(SU4@\YKU.2-9HV1E5E88 M92,@BOS,_P"#HSPOIZ_L.>!=2%G;K>V/C>VLH)E0!HH7T^^9HQZ*3%&<=/E% M>?EM/#9IBJ6!E35-R=N:%^JTNI2EM;HUN:UI3HPE4OS6Z/\`X"1^BW@'XI>% M_BOILU[X7\1Z#XEL[>7R99]*U"*\CBDP#L9HV8!L$'!YP17/^(/VK/A=X5UJ MZTW5/B3X!TW4;&0PW-K=>(+2&>WD4X*.C2!E8'J"`165^PUHMGX=_8M^$EG8 MV\5K:P^#M)V11KM49LXB3[DDDD]222>37YC?\'7VG6\-_P#`BZ2"%;J=->CD MF"`22*ATTJI;J0I=L`]-Q]:C)&;7=YVKPZG!)8P[A:5I5MH>FV]G9V\-I9VD:PPPPH$CB11A551P M`!P`*_%?]AWX&^"_BI_P&/$7A^WFU^XBTS4]+@N[..47L(#B M&12@8;VP<9^8^M+)\JPV,IXBK4E**I1YM+-M7M;IKYCQ%>=-Q2M[SL?L%X!^ M/O@3XKZM/I_A;QKX3\2WUO%]HEMM*U>WO)HH\A=[+&[$+N(&2,9(]:R]5_:V M^%6@ZI<6-]\3?A]97EG*T%Q;S^(K..6"1259'5I`58$$$$9!%<[\$?V%/AO^ MS;\:-:\9>`_#>D>$Y-=TB'2;K3]*M%M;5_+FDE\W8N%WG>J\`<(/P_.7_@XY M\*Z9J7[8/[-AN-/LYCJUS+9WI>%6^UPB\LP(WX^90)'X.1\[>IJLHRK!X_,% MA*!_P!H'P'\3]4:Q\,^-O"/ MB&\1=QM],UBWNY0.3DK&Y.,`]NQKL*_)W_@O_P#L*?#GX`?L[>'/BY\,_#VB M?#3Q?X7\06MJLWARW32EN8Y!(5*QP!5$\*UV^)=<\+:;?ZH2NTM<2VL;R,5P-I+$DK_"21VK#,,KHT\%2Q^&F MW&;<6I))IJW9M-6>^A5*M)U'2FM5KH>@:QJ]KX?TFZO[^Y@L[*QB>>XGF<1Q MP1H"S.S'A5`!))X`%5_!_B_2_B!X4TW7=$U"UU31M8M8[VQO+:020W4$BADD M1AP592"#Z&ODG_@MA\7-8_\&WW[4<_Q2_9(U;X9:U(Z>(OA/J#6BPS<3"PG9WB!!YS' M*)X\?PJL8XR!3AD-264RS1/:25O[KTYO3F]WY,'BDJZH^7X]ONU/NKQ]\>?` MWPHU*&S\4^,_"GAJ\N(O.B@U75[>SDE3)&]5D=25R",CC(/I6/8_M>_"?4[R M.WM?BA\.[BXF.V.*+Q'9N[GT`$F2?I7AO_!<[0[/6O\`@EG\5OM=K!<&SM;. MY@,B!C#(M];X=3_"P!(R.S$=":^9?V!_^">_PK_:W_X(7^&6\1>$_#T/B:XT M[7;FW\316,46J6EQ%J5\(I#<*!(ZJ(XP49BK(@4C`&.G`Y1@ZF71Q^(G**]H MJ;LD]X\W-T^[\2:F(J*K[*"6U_QM8_4+7?$5AX7T.ZU34[ZST[3;*(SW%W=3 M+#!!&!DN[L0JJ!R22`*X>T_;!^$M]=1PP?%+X=333.(XXX_$EFSR,3@*`),D MD]A7Q+_P;+?$SQ;X[_8D\1:=KUU>7VB>&/$;6&A37#%S!";>&22V0G_EFC.& M`[>:1T``\,_X)M>'=/M_^#BSXX1QV-G''8R>(9K95A4+;N;V$%D&/E8AW&1S MAV]373_JS3IUL90JS;>'CS76TMM/+?SL9_7&XTY17Q:>A^M/C_XY>"?A+>6] MOXJ\8>%O#-Q=H9((M5U:"S>9`<%E$C*6`/&17/\`_#9GP?\`^BK?#7_PIK+_ M`..UY;_P64T>SUK_`()D_&!;RU@NEM]%-Q$)8P_ER)*A1UST92,@CD5\M_\` M!!O]C'X1_'W_`()R6.I>-?AEX%\4:M<:YJ$,FH:CHEO/>E%==J^>R>8`.P#< M5QX/*<)+*WF->4ERS4+))[J]];?=^)I4KS5;V44MKGZ6>$/&6C_$'P];ZOH& MK:;KFDWF[R+W3[I+FWFVL4;;(A*MAE93@\%2.HKC?BS^U]\*?@/KD>E^-?B1 MX%\*:I,%9+/5= MC1(FBRSR?O98D(YW'>P!)R6/)R2:_.C_`(-[_B1\&_CMX&\9^&_'6G>'=>^- MFOZS=:GJL_B2UBO+WQ':R*IS&\RDN$/F;XAR,ER,,2(P>44JU#$8Q.4J=)I6 M27,TV[2=]DDM='J_F54Q$HRC3T3E]VG0_5+X??$OPW\6_#4>M>%?$&B>)M'F M8I'?:3?Q7ML[#&0)(V921D<`]Z*X?]DO]E70OV/O`^N^&?#,=O;:#J7B&]UN MSLXHO+33TN65OLZC)RJ$$+Z+M':BO$Q,:4:LE0;<;Z-Z.WF=$.9Q7-N>J5Q/ M[0WP!\,_M0?!_6O!'BVR^V:+K:?\``[Q]J/\`H5R_E>$=1N7_`-1(QXT]V/\` M"Q/[K/1CY8R&C5?L+_@KE^SY\,_CY^S%=0^/?$WAWP3JNDB2Z\.ZWJEPD/V> MY"C,0S\\D'RY/WD+_+)&W<'@J?U!KU:/43P]2\=C^@/_@KM_P3>D_X*2_L[V/A_2]:M]!\5>&K\ZGI%Q=JS6D[&-HW M@FVY*JX*G>%9E*#@@D'\4O&7_!"+]JCP=X@DL?\`A5MUJB+)LCN].U2RGMYA MSA@?-#*IP?OA3TR!D9^IO`W_``<3?%[P3\+=%T.3P]X1U[6-+M1;S:SJHN)9 M;\KPLDB1R)\^W`8[OF(+<9Q5&[_X.*?CU<7#R)IOPYMU8\1QZ3<%4]ANN"?S M-;X/$8K#Q]G&S7F?J7"GBYF60X7ZGAU&=.[:4D]&][--/?H[^1TW_!)?_@@- M\3?AG^T7X7^)WQ<^P^$K/P?>IJ=CHD%Y'>7][8\+-%'&&VL<.S-MVE5 MSN'Z6?M__MP^'_V#_@1=>*-4$=]K5WNM="TGS-KZE=8R,]Q&F0SMV&!]YE!_ M,7PS_P`'(?QFTZ6-=4\)_#C4X%'SF*TO+>9^?[WVAE'&1]ST/."#\J_ML_MI M>+/VY_C--XN\4-':QQ1"VTW3('+6VF0#G8F>26;+,QY8GL`H&595L15YZ^R[ M'S?%G'&-S_$?6\8US)6BDK**WTU;W[MOY'"_&#XN>(/C[\3]8\7>*+^;5-?U M^Y-Q'-0T?5+:.^TS5;:2SN[>0?)/#(I1T;V920?K7X6 M?L)?M*2?\$8?VJOVE_AOXDN!]FT_2+R;1%NC\NHZA9[I--^4=/M$$^XX.>5S MTX_>&OS@_P""H_\`P1NU+]MK]O7X7>.-'@M8?"]XB67CR9ITB:*WM9`\;JI. M^22:)G@&T$)Y49;`R:^PX1S#"P=;!9@[4:D;OUA[R^_5>;LCS\=2F^6I2^)/ M\]#VC_@B;^SE=_L_?L$^'+S6A,_BSXBS2>,=;FF_UTDMYM:(/D!@PMQ#N!Z. M7]:\J_X.9_\`E'-8_P#8XV'_`*(NJ_0>UM8["VC@@CCAAA0)'&BA510,``#@ M`#C`KXF_X+<_LF?%3]NOX#Z'\/?AWH%C)'9Z[;ZY=ZG?:O%:PNL<%S%]G$?+ ML=TR/DX`V#J3QCDV8*MGT,=B)**<^9MM))=M>VR*Q%'EPSI0UTL>^?\`!/'_ M`),`^!O_`&3[0/\`TVV]>"_\'#7_`"BQ\;?]A#2O_2Z&O!_#MAHC7%OJ4-Y;7YMH5@#IM.YVQ56+>%<4M;6_`G_X(B?\`*+'X0_\`8/NO M_2ZYKRK_`(+N>/O$'Q$\)?#O]GGP1I=[XC\4_%[5_M-]I5C=PVUQ/I5ABXF3 MS92$BWNJL'<[<029S@BO5O\`@F+\,_B=^RI^QIX=^&_C3P3#_:_@VQO!#=:? MK%M-;ZF6NI)8HER0T;E)<$L-N8R/X2IG=>1S7=3G1IYOB,PW8,WRJRS+&P)X!4'M7R+_P1\_9V_:*_8`^%NK^ M`/'7@W2?$/A>:^.HZ3/IGB&W,^FR2`":)DDVAHF(5QA@58OPV[Y7BL90S+)H MQ?+3JT9/ECS/WH2U=N>3;:EKOML*%.5'$-ZN,EJ[;->B['BW[/3;(JA&"-,8RX9.0O4#(;3B+#T\4Z%6E6A:% M&"E[\;IQ3NDKW;Z*U[L6#DXLG;1]3ZZK\>?^#L/_F@?_ST'P+'?11W.HZY#&U\]R\.76-02J[ M;=/O'//08YX^",12H9Q2Q%>:C"/-=MI;Q:6_FS3,8REAW&*NW;\T?IK7YM_\ M'1O_`"8!X/\`^R@V7_IMU.OO?X/^*?%'BGPM')XN\+?\(KK$:(LT":A#?0RO MM^=HWC_A#9QN"GVKX\_X+A?L=_%G]OCX6>&?`OP]T#3Y++1M976[K4-0UB*V MBF9;>6%42/EBP\Y\D@`=LY..?A>4,/G%&=>2C&,KMMJVB[WL_D5C+SP\E%:L MM_LO?\$D_A%XT_9G^'>L7TGQ#-[JWAG3;RX\GQOJL,9DDM8G;:B3A47+'"J` M`.``*^"/^#BC]C;P9^R3_P`*>_X1%O$C?\)!_;7VO^UM?O-4_P!3_9^S9]HD M?R_]:V=N-W&%?'7AI=!UKPCH.GZ1-/#J,-Y;ZE) M!`(7EC,>"H/EJV&48\S`W;23\:_\%R/^"?7QF_X*+>+O`=KX&\,Z1;Z3X#74 M`;[4=9AA;4&NOLOW(QDJJ_9OXL$ENF!D_0<.9Y6AGJ>+Q'[I.=[S]VW*[=;/ M5K^DA(!["OV-\!^,O%FJ_#J2^U_P`'3:3XBM8` M3ID6HV]PMY*(P3YZFQT:_P#$RQ.MK=3"15\U%(612D9)VL.&&.01P<+5EAZ>+BZD83E# MEBW)*\KWT=_QV-<;'G=-V;5[O1['V_\`LB_L(V_[(OQD\>ZYI_BKQ5XHTCQ= MINE6]J/$FKRZI?Z;+;27QF1)9!D0.+B!@NXG>LF>-M?!'_!RA#?7/[3_`.S7 M'IDT-KJ4ES=+:32IOCBE-W8[&9>ZAL$CN!7VW^SSX@_:0^*?[3%IJGQ.\"^' M?AMX#\/Z+>Q16NF>(EU:36[^:6W$;OMV[4CBCE(W("#)WS\OSQ_P5V_84^./ M[;?[27PV\0>"?">AQZ+\,I7ECFU+6XH9-3D-S%)D(NXK'M@3&[#99L@8&=\A MQ#HYW#$8VM!OE=Y*O#]CJFE7=KJ&EZA`ES:7-M()(;B)U#(Z,O#*RD$$<$&O)? MVB?V:M'_`&^OV8=6\#_$CPY$M1F\0M8R:5*ZDIF. M2-B8-^&:'C:Q?:[`\\>*EA\RP,(J4:=:E=.-U&$DW?FC]E2_F[JS6R1I!2HU M&[-QEUW:\GUMV.9\=?&/X@_M"_\`!8?7/&?P^^%5]\7O#/[.FGOX5M((/$%C MH\-IJ]TK?:;@/=L`[*!-"50$CRHV)7*[OG[X2_$OQ=_P3_\`^"YT/B+QQX#O M/A5X>^.EPZW6CW&L6NIQQ)?R@>=Y]LS1874$WXX9(V(.`03^AW_!'[]ECQA^ MR%^S5J'AGQ]HL=IXPU+6KK7-8U:/4HKU-;N;AV^<%?G4K%'""''+$D9R<<'_ M`,%R_P#@G%XH_;\^&W@9O`-C93>,_"NIRLMQ=7B6L:64T?[U2QY+>9'`5P#C M:_3->S@\XP4<=++*BC[!P]ESW>R5U+XN36=Y;)J_>YSU,/4=+VROS7YK?IM? M;S/0O^"W?_*+'XO?]@^U_P#2ZVKP3_@E_P#LT>)/VI_^"-WPR\)I\1-0\&>" M=;L]7LM:M='TV/\`M34(VUK4/-C2\D9EBCD0A&40EB`WS88K7;?M+_"_]I'] MI_\`X)FZA\)=;\!Z/'\1M8L;+3K_`%I?$EN^GW`@N89'N#D>9YDJ0D%=N`TA M(;``KT#_`()%_!/XF?LF?LG^'/A7\0/"]I8R^&7OGAU6QU:&[MYTFNY+E5*# M$BONGD'0C"`YYP/,C66$R1T:=2#J1K\R2<9:*%N9)WZ[=>IMR\^)YFG9QMU6 MM]CWC]G7]G?PE^RI\(-'\"^"-+72?#VBQE88MQ>25V)9Y9'/+R.Q+%CW/&`` M!^6/_!-__E8R^/7_`',/_I=;U^O6O7MSINBW5Q9V,FI74,3/%:I(D;7#`<(& MGAK]IC_`()^VVO:EXT^ M+'AV_NM6U"T">'?%MSIUK$%8`.L"GR]W.22IR>M?:\U**UM],7S8F8N227)3S`NP$;EY(!!KY=_P""?7PA M_:\_X)W?LW_\(#9_!_X?^-K6WU&:_@F7QFEC.OG%2R$-&4;!!.XN?!_AVTL-1OO.)AEFA@43S;W`.PNKME@#@\XK\W_^"O7_``1*N8-9 MUSX]?`FXN=%\3:9(^OZOH5I(87DD3,LEY8.N"DP(,AB!^8Y*$-A&^O;?X*_& M?XV?\$Z?B7X;\=2:7I/Q5^(UIK*QV<6I-+8:.+@/%;6RS+O(C6()G;N&68]R M*XK3OCA^V=K?P9;PA>?L^^&[7QK+8'3G\87/CBQ.CF0IL-X;./=<=]QC'&0> M<86N7*,1BL)BY8O#5XK7-%N_P`.JW6Y5>,)P4)Q=K::.Z_R M9T/_``17_;KUG]O+]C6'7/%7ER>+O"^HR:#JUS&@C74&CCCDCN=HX5GCE4,! MQO1R`H(`*[#_`()??L$6?_!.W]ERT\$_VA%K.N7UY)J^N7\2%8I[R1$0K&&^ M;RT2-$7."VTL0I8@%>#GD\+/'U98)?NW)\OIY=EV\CJPRFJ454WMJ?0.M:U9 M^&]'NM0U&[M;#3[&)KBYN;F58H;>-069W=B`JJ`222``*_.K]I'_`(+#^-?C MIXUO/A[^RGX0U+QAJD9\FY\4_8#-;VY.?F@C<"-5!'$UP0A((",-KGZ/^,_[ M+>N?MS>)%M?B%>ZAX>^$NFS+);^$[&X,-YXFD4Y$^HS(>[$*/F8XY8Y)/4FN&+A'5Z MO\`DIST6B_$_*OPA_P`$&_C1^TWXH/BKXX_$R'3]2O@&F0R/K6HJ/^>98LL, M8'81NZJ.@[5T'[7G_!O5H7@7]G&\U3X5ZIXGU[QMH>;R:UU*6*0:O"%^>*%( MXUV2#&Y!EBQ!7DL"/U6HJOK52]R/JE.UC^5?0]6G\)>)+2^6WM9+G3;E)A!> MVJ7$+.C`[98I`4=+(_AS\,='U;0 MXA%XET^30K)%TJ55):3+)Q`ZJSHYXP&!.Y&`^3/^"Z/_``3"'A&_OOC;X!T[ M&EWDGF>*].MX^+25CC[A(/=*,:\$XNS.",I4)M25SZ"_X*D? MM5^"OVD?CN]K\-_"?A;P[X)\,[K.RN]-T:WLKG66S\]Q(Z(KF,G_`%:,ZE(REI"Q!&]A@L<'8 MG/!9,^4?L8?LA^)OVV?COIO@GPVGD^=_I&I:@Z%H=*M%($D[X],A57(W.RKD M9R/Z)_V=/V??#?[+GP=T7P1X3L_LFCZ+#L4M@RW4AY>:5@!ND=LL3[X&``!- M>LJ4>2&Y6'HNK/GGL?GO\;?^#:KP[J*37'P[^(FK:7)@M'9:_:I>1NW]WSH? M+9%^L;GCOUKD_!7Q&_;(_P""4#1P^,M!O/BK\+M/XFD@N6U**SA7JT=R%^T6 MR@8`\]/+'0*.M?K917']9DU:>J.[ZK%.\-&>/_L>?MQ_#[]M_P`!'6O!.J^9 M<6H4:CI-T!%?Z6[=!+'D_*><.A9&P<,2"![!7SC\:?\`@F_X7\2_$6+XB?#B M\D^%/Q2LB7BUK1H0+34'1?$=F?L]_%:RF:RFD'_+:VD(!:%Q\RA@'7.U@"#G*2CO$T@Y;2.HHHHJ M#0**\G^/W[1NM?`71/$6MR?#GQ%KOAGPQILNJWFJ66H:?&GD0PF:4K%+.LI* MJK#&WDCC.16W\)_BMXC^(EXO]J?#[7/"NGS6GVF&]O-1L+A)22FV,)!,[ABK M%LD``*02"0#7*[7)YE>QWM%>1VO[8OAN[_:,;X=K9ZMN\]],37#$O]ERZJD` MNGTQ9-V?M`MV\W&,85ESN4K6Y\?/CM_PH^V\+I#X?U3Q-J7B_7%T&PLK&:"% MS,;6YNMS/,Z(JB.UD_BSDBCE>P#O# MG@_Q!XVUZQTZ#5=133Y[.W@TVWGDFC@\R2XFC'F2-!+M10QVQL3M&W)RL.=' MIE%>4Z;^TCJNG^+M#TOQ5\.O%7A*#Q%>?V=8ZA-=6%]:_:C&\BQ2?9[B22/> ML;[6*%,C#,I*[JM[^U!K%_\`%+QAX8\-_#?Q)XH;P3>6]A?WMOJ.GVT+336< M%XH03SHYQ'<("=N,@T"+K4I/AGK\.J0W*PQ:0VJ:<9 M[B,@$RB07'E!021AG#<<`\5P_AS]KSQ1XK\:>(O#]C\'/%TFJ>%)+>+48CK& MDJL+3PB:/#&ZPV48'C..E'*V'.CW:BN0TGXP6>J?&O4O`OV.\AU32]`LO$$T MK;##Y5U/=0+&""3O5K1R>,89<$\XXO\`9:_;5\,_M3+<6]E8ZOX*13'+&ZO&[*0XZ,&42?& MKXN6/P/\!?\`"0:A;75W:C4M.TSR[?;YF^\OH+.-OF(&U7N%8\YV@XR<"ERN M]A\RMP.26YZU17.>/_BOH/PS^%NJ>,]5U"WC\.Z3I[ZG-=QN M'1X53>"A!PY88"@'YBP`SD5PGB_]J*^\+M\/[&#P#XDU#Q%\0+*XOH-'2YM+ M>?3E@BBDD2=I94C#J)E!"L>01SUIJ+>PG)(]>HK@_A_\3O%GBKQ$MGK'PUU[ MPQ9F-F-]=ZIIUQ&K#HNV"=WR?7;CUQ7'>"_VL?$7Q,TNYU/PW\)O%>KZ/#J5 M]ID5X-5TN!;A[2[FM)6"27*N%\V!\;@"0`>]'*PYD>VT5PWP4^.$'QC/B*UD MT75_#>N>$M172]7TO43`\MM*UO#:>.!%4NRJ/FD7DD#&:7*[V#F5KG945Y3_P MO3QY%\TGP3\8M&O+"+6M&9R.^T&\`)]`2`3W'6K#?M5^';GX7>!_%UC#J5YI M7CS5;'2;(>2(IK>6ZD\L>:CD%?+<$.!D@J<9I\K#F1Z=17E?BG]I.\@^)VM> M$_"_@7Q)XRU#PW';OJT]I#M8M[%=2C&H-:W%K>0F0QDQ3VTTJ[E;&Y'V-\P(#+S1R MO<.97L>A45X?X!_:T\2?%/PTFN>'?A'XLU+1Y[BX@M[HZMI4/G^3/)"[!)+D M,!OC;&0#BO7/"&M7NN^&+6]U/2+GP_>3*6FL;F>*:2UP2,,\3-&<@`_*QX/K MD4.+6X1DGL:E%>2_L^?MA>'/VC/%6KZ5I=GJVGM9Q?;],GOHECB\0Z?Y\EN+ MZT()+P&6)AD@-AXFP%D4G2^)O[0DG@SXDVG@[0_"7B#QEXDN--.L36^GS6EO M%8V@E\I9)9+F:(9=]RJJ;V.QB0H&2D45YGX0_:!U34?B#I?AOQ' M\/?%OA&ZUJ*>2QO+F6RO+*9H5#/&TEM/(T*_% M/BBP\,_"_P`3>(K7PIK$NB7-[%J>FV\"5HQ97=U;W$A4`8?=!(Z8.2,;L\=.E%24;U%%%` M!1110!7U;2;77]*NK&^MH+RRO8F@N()D$D<\;`JR,IX92"00>"#7X6_\%*?^ M"1_B3]GO]I71[/X=:/J&N^$_B-J`MO#\,*[WL+M\L;*1CP`H#.KL0/+5BQ_= MNU?NU36C5RI958J(M5C7_`(_+@`XC0GYO)BRRH#C.68@,[5]!T45G*3D[LTC% M17*@HHHJ2@HHHH`****`/._VO/!VI?$3]D[XH>']%M6OM8UWPEJNGV%LK*K7 M$\MG+'&@+$`%F8#)('/-2?$K5?%O@G]GYAX/T5=8\9+8066G6LLBI!#3$29'QR5C(7)(KT"BJYNA+CU/D>;]AOXG)^S?;?#V#Q?\/XY+&Z75X- M=_L&\_M4:NMQ]J_M(R?:ROVAKC+L=N"&9<;3MKJ/BSX`\F:G;R30RY.8GFDBV$98I,N0#NQ](457M&3[-'S M7^TA^R+JEY\,EFT7Q)\0/&.I:=JVF7\6B:KK8FL-16*^@>1)XR$#H(U=]I8< MHIYP`=_Q#;>)/@Q^U9XJ\8VO@SQ!XP\/^-/#ND:>)-$>T,^G75C-J#,DD4\T M19)$NU*NA."C*0,J3[K12]H[68_9K='R_H?A_P`=^)_C)X3N-#M_C5H.G0ZT M;[7I/%.JV+:8;$13$VZ0Q322,[RF%5`&%4,2PP`V'K_PDN=+_:@^+FL:UX'^ M-6K67B35]/N]*O/"'BVYTFSGACTBQMWWQP:E;`R":&5=SH6PHY(P!]>44_:, M7LT>>_LXV\-AX*N+:WT'X@Z!#'=LPB\8:Q+JM[*2JY9)I;JY?R^P4R``AL*, MDG+^#W@'6/#?[1_Q@UJ^LY+?2_$=WI4FFSEE*W2Q:?'%(0`K M45/-N5R[>1Y3HG@'5[;]MWQ1XHDLI%T&^\#Z/I4%WN7;)#?B!X*CDN=(UFR=#?Z!=&5SE2"4 MDB=2HDA8E)%.",@%?IJBCG:%[-=3Y2^&GPG^)WQ.\4?'F+QYH%EX=U3Q5X,T MSPG:ZG;3K-INKSQ+JZO=P*&,J1$7<#%)`&4LR_-MW'8M?&/BC4/@OX9\+ZM\ M-_C5X>U30[2UANI_#E[I8$DD,/E,J3B[_>0DY8952<*2%(*U]*T57M/(7L[= M3R3]C_PYXQT'P9XBF\7S^)"NJ:]-=Z)::_>0W>I:=IWD01QQ3O"S1[FDCFEV MJS;1,%)W`@,_;D\(:UXV_9VNK/P_I-YKFIV^NZ#J*V-JT8FGBM=9LKF;9YC* MNX10R-@L,XQ7KU%3S>]S%#S@\BO6J*.;L'+K=GR5X'_9R\=S^,-"^$FN:;,_P9^'NK'6[#5Y; MJ*0Z_9PF.72]*DCR7Q:S,^\LH#I8V_)\QJZK]M'X8ZAXQ^,OPMUE?#?CKQ#H M>@1ZPFH#PIK,FE:A;M/%;K"?-CNK:3:2C9"R8..0>*^BZ*KVCOKZ>BY5L"*;4KE5D)4`.L88#<-P#$'F M_P!FK]D/5]+^&=PNN>*?B)X8U"Y\1:]>?V=I^M+#;0PSZQ>30NBJK`>9#)') MUSESG!R!]+44N=A[-'C7[*'P@U3X->+/BI8WRZE>6.I>)HM1TW6M3NA=:AK, M3Z;9!VEDSDB*998$!"[4B4`$#<;?[M44N9\W,5RKEY3R:;]I?76B;[/\`!OXJ33X/ MEQLFE1"1NREFO@JY/&20!WKSJQ_9P\5>&OV8_@[X=:Q6ZUK0O&FFZ_K4-O,K M1V*M?R7=R`Y(#K$92N1RP7(!S7T]13YK;"Y+[GS%\=OA9/J/QU\0:I?>`?B9 M-;:A;V8LM=^'GBJ729[Y8XV5X;^-+^WWO&Y/EOY;#8P&\$%:T/V8?`_BWPY\ M<;BYMK/XJ:3\/6T&6*YM_'7B,:QV6G.)+V>6, MPPPZO#&BF-T)"QKSDD9))]9^/?A?QK\5OV7>VWF6 MS+@A'--^-FC^&('NSXG/C MKQ9_:UK=0&UD%O'!%)>7,@F%R8FWH$4(KAF.Y17/Z1\(+CPS\4/B9<:_X#^. MFH-KGBVZU.QNO"GC*ZTO3Y[5X8%1O)@U2W7?N1\DQ[B`,DX`'V-11[1A[-'$ M_L_Q16OPZCMX-%\;:##;SR(EOXKU234M1;)W%S/)KN:+16/_9 ` end